- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06888713
Telemonitoring of Activities of Daily Living in Home Care Services of Older Adults with Cognitive Deficits
March 14, 2025 updated by: Nathalie Bier, Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Telemonitoring of Activities of Daily Living in Home Care Services of Older Adults with Cognitive Deficits: a Large-scale Action Design Research Study
In Canada, it is estimated that two million people are users of publicly funded home care services, with more than half of them being 65 years and older.
Although home care services are considered a priority by Canadian provinces, in Québec alone, more than 46 000 people were waiting for those services in 2022.
The provision of home care services is hampered by limited funding and growing demand from among an aging population, among other factors.
These challenges have led to urgent calls to better support home care in Canada to ensure optimal use of scarce human and financial resources.
One of the key strategies to achieve optimal use of resources may be remote monitoring of activities of daily living (ADLs), a type of telehealth.
ADL telemonitoring can remotely recognize ADLs such as preparing meals and moving around the home.
Past studies have shown that ADL telemonitoring can help in better understanding older adults' home care needs, thereby allowing for more personalized ADL interventions.
Previous projects have also allowed for the developement of NEARS-SAPA, a telemonitoring system for ADLs.
In these past projects, it was identified how NEARS-SAPA was used by home care services and its ease of use was tested in real environments.
In the present project, the benefits of ADL telemonitoring will be tested and its technological capabilities expanded, hence preparing the system for the next big step, i.e. large-scale adoption by home care services.
Ultimately, ADL telemonitoring may help the healthcare system determine which service is more appropriate for which person and at what time, thereby optimizing interventions and resource management.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Maxime Lussier, Ph.D.
- Phone Number: 514-340-3540
- Email: maxime.lussier.ccsmtl@ssss.gouv.qc.ca
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
1) be an older adult (> 65 years old), 2) have cognitive deficits as reported in the medical record, 3) live alone, at home, 4) be a care recipient of home care services, 5) speak French or English
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Telemonitoring of ADL group
Will receive the technology in their home to document if it influenced the homecare services plan.
|
Telemonitoring of ADL is based on smart environments sensors (non wearables) and gathers information about activity of daily living routines for a better understanding of homecare services needed.
|
|
No Intervention: No telemonitoring of ADL
Another group will be followed in therms of homecare services received, but without the technology.
The control group will be gathered based on archives data only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of homecare services received to support activities of daily living (ADL)
Time Frame: From enrollment until around 12 months of following.
|
Number of homecares ADL services received as identified in clinical databases.
|
From enrollment until around 12 months of following.
|
|
Nature of homecare services received to support activities of daily living (ADL).
Time Frame: From enrollement until around 12 months of following.
|
The category of services received related to ADL as indicated in clinical databases.
|
From enrollement until around 12 months of following.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Nathalie Bier, Ph.D., CRIUGM, Université de Montréal
- Principal Investigator: Charles Gouin-Vallerand, Ph.D., Université de Sherbrooke
- Principal Investigator: Kevin Bouchard, Ph.D., Université du Québec à Chicoutimi
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2025
Primary Completion (Estimated)
April 1, 2028
Study Completion (Estimated)
December 31, 2028
Study Registration Dates
First Submitted
February 28, 2025
First Submitted That Met QC Criteria
March 14, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 14, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PJT-195697
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.